"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancerChristian Grommes, Andrew B. Lassman, Geoffrey R. Oxnard et al.|Neuro-Oncology|2011Cited by 343
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, J Costello, Yalan Zhang et al.|Neuro-Oncology|2020Cited by 96
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto‐Hope G. Lucas, David A. Solomon, Nicholas Whipple et al.|Acta Neuropathologica|2022Cited by 50
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastomaCalixto‐Hope G. Lucas, David A. Solomon, Rohit Gupta et al.|Acta Neuropathologica|2021Cited by 44
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’Rohit Gupta, David A. Solomon, Calixto‐Hope G. Lucas et al.|Acta Neuropathologica|2021Cited by 33